CopyMark Law Group
4.9/5
Drawing for AMZANSU

USPTO serial 79402401

AMZANSU

Reviewed by CopyMark Law Group

Reg. 7772921Status 700Registered
Filing date
Status date
Registration date
Apr 29, 2025
Examiner
BEAUDRY-TORRES, FAITH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMZANSU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn M. Eyster

Kathryn M. Eyster Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 14, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 14, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 11, 2025FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 23, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 23, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 29, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 29, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 12, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 6, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 1, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 31, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2024DOCKASSIGNED TO EXAMINER—
Oct 1, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 1, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 15, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance